Peer-reviewedCC BY-NC-NDTranslational Lung Cancer Research
Exploratory study to evaluate the combined effect of CBM588: Clostridium butyricum in platinum plus pemetrexed with pembrolizumab for non-small cell lung cancer—protocol of MIYABRO study
14 affiliations
- 1Department of Respiratory Medicine , Nagasaki University Graduate School of Biomedical Sciences , Nagasaki , ;
- 2Clinical Oncology Center , Nagasaki University Hospital , Nagasaki , ;
- 3Department of Laboratory Medicine , Nagasaki University Graduate School of Biomedical Sciences , Nagasaki , ;
- 4Department of Respiratory Medicine , Nagasaki University Hospital , Nagasaki , ;
- 5Clinical Research Center , Nagasaki University Hospital , Nagasaki , ;
- 6Department of Internal Medicine , Nagasaki Goto Chuoh Hospital , Nagasaki , ;
- 7Department of Respiratory Medicine , Sasebo Chuo Hospital , Nagasaki , ;
- 8Department of Respiratory Medicine , Sasebo City General Hospital , Nagasaki , ;
- 9Department of Respiratory Medicine , Nagasaki Harbor Medical Center , Nagasaki , ;
- 10Department of Respiratory Medicine , National Hospital Organization Nagasaki Medical Center , Nagasaki , ;
- 11Department of Respiratory Medicine , Nagasaki Prefecture Shimabara Hospital , Shimabara , ;
- 12Department of Respiratory Medicine , Japanese Red Cross Nagasaki Genbaku Hospital , Nagasaki , ;
- 13Department of Respiratory Medicine , National Hospital Organization Ureshino Medical Center , Saga , ;
- 14Department of Internal Medicine , Japanese Red Cross Nagasaki Genbaku Isahaya Hospital , Nagasaki ,
Related
- Laboratory diagnosis of the first case of Type E botulism caused by Clostridium butyricum in Xinjiang
- SRC Activation Drives Acquired Pemetrexed Resistance in Non‐Small Cell Lung Cancer and Is Targetable by Dasatinib
- DRESS during chemotherapy with carboplatin, pemetrexed, and osimertinib for lung adenocarcinoma: A case report
- Third-generation EGFR-TKI plus pemetrexed-platinum chemotherapy versus TKI monotherapy as first-line treatment for EGFR-mutant lung adenocarcinoma with brain parenchymal metastases
- PemToxTrial: An Observational Study of PEMetrexed-Associated Severe HematoTOXicity in Lung Adenocarcinoma with Bone Metastases
BibTeX
@article{tagawa2026exploratory,
title = {{Exploratory study to evaluate the combined effect of CBM588: Clostridium butyricum in platinum plus pemetrexed with pembrolizumab for non-small cell lung cancer—protocol of MIYABRO study}},
author = {Ryuta Tagawa and Hirokazu Taniguchi and Norihito Kaku and Kazumasa Akagi and Hiromi Tomono and Noritaka Honda and Yosuke Dotsu and Midori Matsuo and Shinnosuke Takemoto and Akisato Itagaki and Koki Yamashita and Yasuhiro Umeyama and Hiroshi Gyotoku and Takaya Ikeda and Nanae Sugasaki and Kazutoshi Yoshiyama and Takeshi Kitazaki and Katsumi Nakatomi and Daisuke Takao and Minoru Fukuda and Katsunori Yanagihara and Hiroshi Mukae},
journal = {Translational Lung Cancer Research},
year = {2026},
month = aug,
url = {https://europepmc.org/article/PMC/PMC13657887},
note = {CC BY-NC-ND},
}
RIS
TY - JOUR
TI - Exploratory study to evaluate the combined effect of CBM588: Clostridium butyricum in platinum plus pemetrexed with pembrolizumab for non-small cell lung cancer—protocol of MIYABRO study
AU - Ryuta Tagawa
AU - Hirokazu Taniguchi
AU - Norihito Kaku
AU - Kazumasa Akagi
AU - Hiromi Tomono
AU - Noritaka Honda
AU - Yosuke Dotsu
AU - Midori Matsuo
AU - Shinnosuke Takemoto
AU - Akisato Itagaki
AU - Koki Yamashita
AU - Yasuhiro Umeyama
AU - Hiroshi Gyotoku
AU - Takaya Ikeda
AU - Nanae Sugasaki
AU - Kazutoshi Yoshiyama
AU - Takeshi Kitazaki
AU - Katsumi Nakatomi
AU - Daisuke Takao
AU - Minoru Fukuda
AU - Katsunori Yanagihara
AU - Hiroshi Mukae
PY - 2026
DA - 2026/08/18
JO - Translational Lung Cancer Research
UR - https://europepmc.org/article/PMC/PMC13657887
SN - 2218-6751
ER -